Patient No. /Sex /Age, y | Site | Enneking stage | Type of tumor excision | Freezing method | Graft length, cm | Bone graft | Union time, mo | Epiphysis growth, % | EWD | LLD, mm | Δ aLDFA /MPTA | Epiphyseal plate at laltest examination | MSTS score | Complications /Treatment (mos) | Follow-up, mo | Oncological Outcome | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Affected side | Cotralateral side | ||||||||||||||||
1/F/8 | DF | IIB | Trans-metaphyseal | Pedicule | 25 | VFG | NA | 12 | 13 | 3 | 43 | 4 | close | 18 | Fracture/ORIF (9) | 90 | CDF |
2/F/13 | DF | III | Trans-metaphyseal | Pedicule | 29 | no | NA | 3 | 4 | 1 | 18 | −2 | close | 30 | Fracture/ ORIF (21) | 76 | CDF |
3/M/11 | DF | IIB | Trans-epiphyseal | Free | 14 | no | 35 | 18 | 18 | −2 | 38 | 1 | open | 30 | LLD/ Lenghning (54) | 68 | CDF |
4/M/10 | DF | IIB | Trans-physeal | Free | 10 | no | 7 | 28 | 29 | 0 | 48 | −1 | open | 30 | LLD/ Lenghning (53) | 64 | CDF |
5/F/6 | DF | IIB | Trans-metaphyseal | Free | 17 | no | 4 | 22 | 21 | 0 | 42 | −1 | open | 30 | 48 | CDF | |
6/F/14 | DF | IIB | Trans-physeal | Free | 8 | cancellous allograft | 6 | 7 | 7 | 0 | 1 | 2 | close | 27 | 51 | CDF | |
7/F/9 | DF | IIB | Trans-epiphyseal | Free | 14 | no | 3 | 8 | 8 | 1 | 34 | 3 | open | 27 | Fracture/ ORIF (35) | 48 | CDF |
8/M/13 | DF | IIB | Trans-physeal | Free | 14 | no | 10 | 4 | 4 | 0 | 24 | 0 | close | 27 | LR/endoprosthesis replacement (20) | 42 | NED |
9/F/11 | PT | IIB | Trans-physeal | Free | 8 | cancellous allograft | 4 | 13 | 15 | 1 | 17 | 4 | close | 30 | Infection/ irrigation (44), Fracture/ Cast (68) | 90 | CDF |
10/F/12 | PT | IIB | Trans-epiphyseal | Pedicule | 11 | no | 7 | 9 | 8 | 0 | 6 | −1 | close | 30 | 90 | CDF | |
11/F/11 | PT | IIB | Trans-epiphyseal | Pedicule | 8 | no | 6 | 6 | 6 | −2 | 33 | −1 | open | 30 | 51 | CDF | |
12/F/10 | PT | IIB | Trans-epiphyseal | Pedicule | 12 | no | 5 | 22 | 20 | 0 | 9 | 0 | open | 30 | 41 | CDF |